290810-88-7

Upstream product

• 3554-96-9 (2-acetamido-2-deoxy-3-O-β-D-galactopyranosyl-α-D-galactopyranosyl)-O-benzyl glycoside 
• 3068-32-4 1-bromo-1-deoxy-2,3,4,6-tetra-O-acetyl-a-D-galactopyranoside 
• 161299-10-1 benzyl (2,3,4,6-O-tetra-O-acetyl-β-D-galactopyranosyl)-(1-> 3)-2-acetamido-2-deoxy-6-O-trimethylacetyl-α-D-galactopyranoside 
• 161299-11-2 2,2-Dimethyl-propionic acid (2R,3R,4R,5R,6S)-5-acetylamino-6-benzyloxy-3-hydroxy-4-((2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-tetrahydro-pyran-2-ylmethyl ester 
• 117181-30-3 benzyl 2-acetamido-4,6-O-benzylidene-2-deoxy-3-O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-α-D-galactopyranoside 
• 90754-57-7 benzyl O-(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)-(1<*>3)-2-acetamido-2-deoxy-α-D-galactopyranoside 

Relevant academic research and scientific papers

Formation of lactones from sialylated MUC1 glycopeptides

The tumor-associated carbohydrate antigens TN, T, sialyl T N and sialyl T are expressed on mucins in several epithelial cancers. This has stimulated studies directed towards development of glycopeptide-based anticancer vaccines. Form

A convergent synthesis of trisaccharides with α-Neu5Ac-(2 → 3)-β-D- Gal-(1 → 4)-β-D-GlcNAc and α-Neu5Ac-(2 → 3)-β-D-Gal-(1 → 3)-α-D-GalNAc sequences

The syntheses of three trisaccharides: α-Neu5Ac-(2 → 3)-β-D-Gal-(1 → 4)-β-D-GlcNAc → OMe, α-Neu5Ac-(2 → 3)-β-D-Gal6SO3Na-(1 → 4)-β-D- GlcNAc → OMe, and α-Neu5Ac-(2 → 3)-β-D-Gal-(1 → 3)-α-D-GalNAc → OBn were accomplished by using either methyl (